Gatekeeping Procedure: Results are provided from a simulation of a phase III study in schizophrenia patients, investigating efficacy at 3 dose levels (Low, Medium, High) versus placebo. The study includes a primary endpoint and two key secondary endpoints. The study includes a total of 9 hypotheses, and multiplicity adjustments are required to control for type I error.
Results are provided from a simulation of a phase III study in schizophrenia patients, investigating efficacy at 3 dose levels (Low, Medium, High) versus placebo. The study includes a primary endpoint and two key secondary endpoints. The study includes a total of 9 hypotheses, and multiplicity adjustments are required to control for type I error.
A description of the challenge can be found here.
A recording of the session can be found here.
(A summary of the discussion will be added shortly.)
No code is available.
No code is available.
No code is available.
For attribution, please cite this work as
SIG (2023, Nov. 8). VIS-SIG Blog: Wonderful Wednesdays November 2023. Retrieved from https://graphicsprinciples.github.io/posts/2023-12-17-wonderful-wednesdays-november-2023/
BibTeX citation
@misc{sig2023wonderful, author = {SIG, PSI VIS}, title = {VIS-SIG Blog: Wonderful Wednesdays November 2023}, url = {https://graphicsprinciples.github.io/posts/2023-12-17-wonderful-wednesdays-november-2023/}, year = {2023} }